Cytodyn Stock Odds of Future OTC Stock Price Finishing Over 13.41

CYDY Stock  USD 0.13  0.02  18.18%   
Cytodyn's future price is the expected price of Cytodyn instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Cytodyn performance during a given time horizon utilizing its historical volatility. Check out Cytodyn Backtesting, Cytodyn Valuation, Cytodyn Correlation, Cytodyn Hype Analysis, Cytodyn Volatility, Cytodyn History as well as Cytodyn Performance.
  
Please specify Cytodyn's target price for which you would like Cytodyn odds to be computed.

Cytodyn Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cytodyn for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cytodyn can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cytodyn generated a negative expected return over the last 90 days
Cytodyn has high historical volatility and very poor performance
Cytodyn has some characteristics of a very speculative penny stock
Cytodyn has a very high chance of going through financial distress in the upcoming years
Cytodyn currently holds 37.35 M in liabilities. Cytodyn has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Cytodyn until it has trouble settling it off, either with new capital or with free cash flow. So, Cytodyn's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cytodyn sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cytodyn to invest in growth at high rates of return. When we think about Cytodyn's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 266 K. Net Loss for the year was (210.82 M) with loss before overhead, payroll, taxes, and interest of (73.28 M).
Cytodyn currently holds about 4.68 M in cash with (77.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.

Cytodyn Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cytodyn OTC Stock often depends not only on the future outlook of the current and potential Cytodyn's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytodyn's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding719.6 M
Cash And Short Term Investments4.2 M

Cytodyn Technical Analysis

Cytodyn's future price can be derived by breaking down and analyzing its technical indicators over time. Cytodyn OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cytodyn. In general, you should focus on analyzing Cytodyn OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

Cytodyn Predictive Forecast Models

Cytodyn's time-series forecasting models is one of many Cytodyn's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cytodyn's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about Cytodyn

Checking the ongoing alerts about Cytodyn for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cytodyn help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cytodyn generated a negative expected return over the last 90 days
Cytodyn has high historical volatility and very poor performance
Cytodyn has some characteristics of a very speculative penny stock
Cytodyn has a very high chance of going through financial distress in the upcoming years
Cytodyn currently holds 37.35 M in liabilities. Cytodyn has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Cytodyn until it has trouble settling it off, either with new capital or with free cash flow. So, Cytodyn's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cytodyn sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cytodyn to invest in growth at high rates of return. When we think about Cytodyn's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 266 K. Net Loss for the year was (210.82 M) with loss before overhead, payroll, taxes, and interest of (73.28 M).
Cytodyn currently holds about 4.68 M in cash with (77.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.

Additional Tools for Cytodyn OTC Stock Analysis

When running Cytodyn's price analysis, check to measure Cytodyn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytodyn is operating at the current time. Most of Cytodyn's value examination focuses on studying past and present price action to predict the probability of Cytodyn's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytodyn's price. Additionally, you may evaluate how the addition of Cytodyn to your portfolios can decrease your overall portfolio volatility.